title: Ending tuberculosis by 2030: can we do it?
abstract: The Sustainable Development Goals aim to end tuberculosis (TB) related deaths, transmission and catastrophic costs by 2030. Multisectorial action to accelerate socio-economic development, a new vaccine and novel diagnostics and medicines for treatment are key advances needed to end TB transmission. Achieving 90-90-90 targets for TB (i.e., 90% of vulnerable populations screened, 90% diagnosed and started on treatment, and at least 90% cured) will help accelerate progress towards reductions in mortality; however, passive case detection strategies, multidrug-resistant TB, human immunodeficiency virus coinfection and outdated pathways to care need to be overcome. Ending the catastrophic costs associated with TB will require expansion of health insurance coverage, comprehensive coverage of TB services, and limited indirect costs by vulnerable and poor populations.
authors: South African Centre for Epidemiological Modelling and Analysis, University of Stellenbosch, Tygerberg, South Africa.
authors: A B
authors: AB
authors: Suthar
authors: Operations Research Unit (LuxOR), Médecins Sans Frontières, Luxembourg.
authors: R
authors: R
authors: Zachariah
authors: International Union against Tuberculosis and Lung Disease, Paris, France; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
authors: A D
authors: AD
authors: Harries
mesh_terms: D000995:Antitubercular Agents / Q000191:economics / Q000627:therapeutic use; D060085:Coinfection / Q000191:economics; D014943:Global Health / Q000191:economics; D015658:HIV Infections / Q000191:economics; D017048:Health Care Costs; D006801:Humans; D015994:Incidence; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control*
chemical_list: D000995:Antitubercular Agents